Growth Metrics

Verastem (VSTM) EBT Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -313.33%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 71.54%
7 Evaxion A 64.16 Bn 64.14 Bn - -79.57%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 9,460.35%
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn -1.33%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.33%
Dec 31, 2025 368.68%
Sep 30, 2025 -6.71%
Jun 30, 2025 -133.52%
Mar 31, 2025 -56.01%
Dec 31, 2024 -4.53%
Sep 30, 2024 -84.97%
Jun 30, 2024 9.16%
Mar 31, 2024 -45.38%
Dec 31, 2023 -80.88%
Sep 30, 2023 -11.49%
Jun 30, 2023 7.59%
Mar 31, 2023 -12.64%
Dec 31, 2022 -1.94%
Sep 30, 2022 20.52%
Jun 30, 2022 -29.91%
Mar 31, 2022 -13.03%
Dec 31, 2021 16.21%
Sep 30, 2021 -273.44%
Jun 30, 2021 26.54%
Mar 31, 2021 60.43%
Dec 31, 2020 48.42%
Sep 30, 2020 143.59%
Jun 30, 2020 45.47%
Mar 31, 2020 0.29%
Dec 31, 2019 -3.33%
Sep 30, 2019 -39.09%
Jun 30, 2019 -129.73%
Mar 31, 2019 -81.01%
Dec 31, 2018 -102.39%
Sep 30, 2018 6.30%
Jun 30, 2018 -36.70%
Mar 31, 2018 -61.86%
Dec 31, 2017 -56.46%
Sep 30, 2017 -191.92%
Jun 30, 2017 -56.80%
Mar 31, 2017 -56.80%
Dec 31, 2016 1.75%
Sep 30, 2016 48.71%
Jun 30, 2016 44.27%
Mar 31, 2016 45.36%
Dec 31, 2015 14.95%
Sep 30, 2015 -15.85%
Jun 30, 2015 -18.08%
Mar 31, 2015 -16.21%
Dec 31, 2014 -23.18%
Sep 30, 2014 -25.88%
Jun 30, 2014 -27.04%
Mar 31, 2014 -44.54%
Dec 31, 2013 -42.96%
Sep 30, 2013 -2.16%
Jun 30, 2013 -50.18%
Mar 31, 2013 -31.52%
Dec 31, 2012 -31.58%
Sep 30, 2012 -156.17%
Jun 30, 2012 -174.65%
Mar 31, 2012 -499.56%